About this role
2‑year fixed-term contract (in the first instance, extension subject to further funding)
About the role:
We are currently looking for a Senior Scientific Officer (MI3) within Myeloid Cancer Biology Research group at the Cancer Research UK Manchester Institute (University of Manchester). The aim of this post is to support the group’s research into myeloid malignancies (including AML and MDS) contributing to the development and running of patient-relevant experimental models aligned to the lab’s genome-editing and disease-modelling strategy; and progressing projects through rigorous data generation, troubleshooting and clear communication of findings. The group uses genome-editing approaches across mouse platforms and primary patient samples/models to understand disease evolution and identify therapeutic vulnerabilities.
About you:
You should have a BSc (or equivalent) in Biological/Biomedical Sciences (or related subject) or equivalent relevant laboratory experience along with extensive practical research lab experience, including mammalian cell culture (ideally primary cells) and experience supporting murine/in vivo models. A current or previous holder of a Personal Licence under the Animals (Scientific Procedures) Act 1986 (PIL A-B) is also essential. You will bring excellent record-keeping and a rigorous approach to data integrity, strong problem-solving and troubleshooting skills, and the ability to contribute to experimental design and interpretation as appropriate.
About the Myeloid Cancer Biology Research Group
Please visit our website to view information about Myeloid Cancer Biology Research Group: https://www.cruk.manchester.ac.uk/research-group/myeloid-cancer-biology/
Why choose Cancer Research UK Manchester Institute?
The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. In spring 2023 the Institute moved into the new
Paterson Building, a £150 million flagship purpose-built biomedical research centre directly attached to The Christie NHS Foundation Trust (www.christie.nhs.uk), in South Manchester.
We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.
How to apply?
Please ensure you detail the names of 2 referees and ensure you submit your application before the closing date specified. Informal enquiries can be made to Justin Loke via [email protected]
Closing date: 26 July 2026 Sunday.
Please note this vacancy will close for applications at 18:00 hours on the closing date specified.